603716 塞力医疗
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-1.778-22.063-19.508-12.135-10.371
总资产报酬率 ROA (%)-0.989-8.949-6.780-4.344-3.726
投入资产回报率 ROIC (%)-1.224-12.364-9.860-6.032-4.957

边际利润分析
销售毛利率 (%)25.15722.31618.32919.57519.863
营业利润率 (%)-10.959-13.658-7.831-8.989-6.433
息税前利润/营业总收入 (%)-9.818-11.289-5.148-5.963-4.477
净利润/营业总收入 (%)-9.474-18.705-10.680-7.815-8.241

收益指标分析
经营活动净收益/利润总额(%)67.76959.83954.39633.2137.248
价值变动净收益/利润总额(%)0.950-3.72343.9771.2353.104
营业外收支净额/利润总额(%)-0.8913.4614.3856.32822.528

偿债能力分析
流动比率 (X)1.6081.4191.5221.7161.607
速动比率 (X)1.3341.1631.2841.4711.378
资产负债率 (%)43.29449.81966.00660.65962.188
带息债务/全部投入资本 (%)26.60032.39049.08944.91248.892
股东权益/带息债务 (%)269.420203.95398.970116.15997.700
股东权益/负债合计 (%)136.277105.20450.01559.73656.971
利息保障倍数 (X)-9.400-3.950-1.693-1.641-1.170

营运能力分析
应收账款周转天数 (天)349.205338.092279.815295.469274.368
存货周转天数 (天)139.750118.23481.28085.05086.043